Latest Institutional Purchases of Aeglea Bio Therapeutics, Inc. (AGLE)
This list provides information on the latest institutional transactions involving Aeglea Bio Therapeutics, Inc. (AGLE) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 11, 2023
Q1 2022
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
BUY
|
- |
11.7KNew |
$21.8K - $55.7K
|
11.7K
$323K
|
|
May 16, 2022
Q1 2022
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
913+ 533.92% |
$1.71K - $4.36K
|
1.08K
$30K
|
|
Q4 2021 | |||||||
Jan 26, 2022
Q4 2021
|
Franklin Street Advisors Inc
|
BUY
|
- |
2.2K+ 2.12% |
$7.7K - $18.5K
|
106K
$2.93M
|
|
Q1 2021 | |||||||
May 13, 2021
Q1 2021
|
Axiom Investment Management LLC
New York, NY |
BUY
|
- |
89.5KNew |
$605K - $767K
|
89.5K
$2.48M
|
|
Q2 2020 | |||||||
Aug 10, 2020
Q2 2020
|
Aisling Capital Management LP
New York, NY |
BUY
|
- |
400K+ 30.98% |
$1.6M - $4.42M
|
1.69M
$46.8M
|
|
Aug 14, 2020
Q2 2020
|
Lion Point Capital, LP
New York, NY |
BUY
|
- |
300KNew |
$1.2M - $3.31M
|
300K
$8.3M
|
|
Q4 2019 | |||||||
Jan 30, 2024
Q4 2019
|
Snowden Capital Advisors LLC
New York, NY |
BUY
|
- |
51.3KNew |
$371K - $438K
|
51.3K
$1.42M
|
|
Feb 14, 2020
Q4 2019
|
Sunbelt Securities, Inc.
Houston, TX |
BUY
|
- |
1.22KNew |
$8.78K - $10.4K
|
1.22K
$33.6K
|
|
Q3 2019 | |||||||
Jul 12, 2023
Q3 2019
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
10.3KNew |
$65.9K - $92.4K
|
10.3K
$284K
|
|
Q1 2019 | |||||||
May 15, 2019
Q1 2019
|
Abingworth LLP
London, X0 |
BUY
|
- |
241KNew |
$1.83M - $2.26M
|
241K
$6.65M
|
|
Q3 2017 | |||||||
Nov 14, 2017
Q3 2017
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
117KNew |
$340K - $576K
|
117K
$3.23M
|
|
Q3 2016 | |||||||
Nov 13, 2017
Q3 2016
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
63.2KNew |
N/A
|
63.2K
$1.75M
|